Isthmus Partners’s Labcorp LH Stock Holding History

Isthmus Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-42	Closed	-$4K	–	250
2015 Q4	$4K	Buy	+42	New	+$4.33K	﹤0.01%	248

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Isthmus Partners's LH Position: Q1 2016 in Review

Isthmus Partners sold out of Labcorp (LH) in Q1 2016, closing a stake of 42 shares — an estimated $4K sold.

Isthmus Partners first reported a position in LH in Q4 2015 and held it in 1 quarter. The position peaked at $4K in Q4 2015. 631 funds tracked by Wall St. Rank hold LH as of Q1 2016.

Isthmus Partners reported no remaining Labcorp position as of Q1 2016 after selling out during the quarter.
Isthmus Partners sold 42 Labcorp shares in Q1 2016, an estimated $4K.
Isthmus Partners first reported a position in Labcorp in Q4 2015 and held it in 1 quarter.
Isthmus Partners's Labcorp position peaked at $4K in Q4 2015.
631 funds tracked by Wall St. Rank held Labcorp as of Q1 2016.

Based on Isthmus Partners's 13F filing for Q1 2016, filed 10 May 2016.